Infection https://doi.org/10.1007/s15010-024-02408-5
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...m interviewed more than120 individuals from approximately 78 organizations, including the government of Senegal (GOS), donors, USAID implementing partners, private sector umbrella organizations, private insurance companies, faith-based organizations (FBOs), nongovernmental organizations (NGOs), private health care facilities, and private pharmacies.
Through stakeholder interviews and review of government reports and online resources, the assessment team noted the following findings by theme.
more
In the last 5 years, the conflict in South Sudan has displaced 4 million people and placed 7 million in need of humanitarian assistance.
This report commissioned by Plan International draws on research conducted with girls and members of their families and communities in multiple sites in South... Sudan and Uganda.
It explores how adolescent girls within two age brackets (aged 10-14 and 15-19) understand and respond to the unique impact their country’s crisis has upon them.
It seeks to amplify their voices and their perceptions of the crisis and presents their views on how the humanitarian sector might respond.
more
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
National Operational Guidelines
A review of Save the Children’s work to promote the rights of children with disabilities
Unite for Children
First Edition
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
Guidelines
HIV testing services
July 2015
This interim guidance has been updated with advice on safe and appropriate home care for patients with coronavirus disease 2019 (COVID-19) and on the public health measures related to the management of their contacts.
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?